News By Tag
News By Place
NuvaRing Cases Move Toward Trial
Ennis & Ennis. P.A. reports that the first NuvaRing MDL trial is expected to take place in January 2014 in the U.S. District Court for the Eastern District of Missouri before Judge Rodney Sippel.
The first NuvaRing MDL trial is expected to take place in January 2014 in the U.S. District Court for the Eastern District of Missouri before Judge Rodney Sippel. As of July 1, 2013, there were approximately 1,500 NuvaRing cases nationwide.
NuvaRing is a birth control device manufactured by Organon USA Inc. a subsidiary of Merck. It is a flexible ring that is inserted into the vagina where it releases fertility suppressing hormones. These hormones pose a greater risk of venous thromboembolism.
Another study published in the May 2012 British Medical Journal reported that women’s risk of developing blood clots increased by more than 6 times when using vaginal rings like NuvaRing, as opposed to birth control pills.
Women nationwide filed suit against Organon, claiming negligence in investigating the device’s side effects, failure to warn users of health risks, falsely marketing the product as “safe” and “effective,”
There are possible settlement negotiations in the works as well. Judge Sippel’s July 30, 2013 Order provides that the parties are ordered to maintain regular and frequent contact with the mediator who will report the status of any negotiations to the Court.
Ennis & Ennis, P.A. continues to offer free, nationwide, confidential consultations to anyone who was injured by the NuvaRing by calling toll free 1-800-856-6405 or by going to www.ennislaw.com and completing an online case evaluation form.